22.74

0.84% 0.19

After Hours: 22.76 0.02 +0.09%

Privia Health Group Inc (PRVA)

Overview News Price History Option Chain Financials Discussions Forecast

Privia Health Group Inc stock is traded at $22.74, with a volume of 992.34K. It is up +0.84% in the last 24 hours and down -3.15% over the past month. Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Previous Close:

$22.55

Open:

$22.67

24h Volume:

992.34K

Relative Volume:

1.20

Market Cap:

$2.77B

Revenue:

$1.80B

Net Income/Loss:

$15.62M

P/E Ratio:

189.50

EPS:

0.12

Net Cash Flow:

$118.36M

1W Performance:

-0.52%

1M Performance:

-3.15%

6M Performance:

+5.87%

1Y Performance:

+31.75%

1-Day Range:

$22.18

$23.17

1-Week Range:

$22.18

$23.73

52-Week Range:

$16.37

$26.09

Privia Health Group Inc Stock (PRVA) Company Profile

Name

Privia Health Group Inc

Sector

Healthcare (1178)

Industry

Health Information Services (54)

Phone

571-366-8850

Address

950 N. GLEBE RD., SUITE 700, ARLINGTON

Employee

1,140

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

PRVA's Discussions on Twitter

Compare PRVA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRVA Privia Health Group Inc	22.74	2.82B	1.80B	15.62M	118.36M	0.12
VEEV Veeva Systems Inc	279.76	38.38B	2.75B	714.14M	1.09B	4.33
TEM Tempus Ai Inc	55.22	10.26B	803.32M	-709.10M	-212.68M	-7.8003
HQY Healthequity Inc	100.61	8.67B	1.15B	96.70M	-161.99M	1.09
DOCS Doximity Inc	52.06	9.63B	550.17M	201.35M	232.07M	1.00
WAY Waystar Holding Corp	39.98	6.61B	906.14M	-52.62M	89.62M	-0.3621

Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-25	Initiated	Needham	Buy
Dec-16-24	Initiated	Macquarie	Outperform
Oct-11-24	Initiated	KeyBanc Capital Markets	Overweight
May-30-24	Initiated	Robert W. Baird	Outperform
Apr-22-24	Initiated	Citigroup	Buy
Mar-06-24	Initiated	Barclays	Equal Weight
Feb-26-24	Resumed	Jefferies	Buy
Feb-22-24	Downgrade	BofA Securities	Buy → Neutral
Dec-06-23	Initiated	JMP Securities	Mkt Outperform
Jun-13-23	Initiated	Evercore ISI	Outperform
Apr-12-23	Initiated	Stephens	Overweight
Mar-10-23	Initiated	RBC Capital Mkts	Outperform
Feb-03-23	Initiated	Goldman	Buy
Dec-09-22	Initiated	Stifel	Buy
Dec-08-22	Initiated	UBS	Buy
Sep-07-22	Resumed	Truist	Buy
May-03-22	Initiated	BofA Securities	Buy
Apr-28-22	Initiated	BTIG Research	Buy
Apr-01-22	Resumed	Credit Suisse	Outperform
Mar-30-22	Initiated	Guggenheim	Buy
Feb-22-22	Upgrade	Cowen	Market Perform → Outperform
Jan-03-22	Initiated	Jefferies	Buy
Sep-27-21	Initiated	SVB Leerink	Outperform
Sep-10-21	Initiated	Cowen	Market Perform
May-24-21	Initiated	Canaccord Genuity	Buy
May-24-21	Initiated	Credit Suisse	Outperform
May-24-21	Initiated	JP Morgan	Overweight
May-24-21	Initiated	Piper Sandler	Overweight
May-24-21	Initiated	Truist	Buy
May-24-21	Initiated	William Blair	Outperform

View All

Privia Health Group Inc Stock (PRVA) Latest News

11:14 AM

Barclays Raises Privia Health (PRVA) PT to $24 on Strong Q1 Fee-for-Service Performance - MSN

11:14 AM

May 29, 2025

Privia Health Group (NASDAQ:PRVA) Price Target Raised to $32.00 at JPMorgan Chase & Co. - Defense World

May 29, 2025

May 28, 2025

Ziegler Advises Integrated Medical Services On Partnership with Privia Health Group - Yahoo Finance

May 28, 2025

PRVA Stock Target Raised by JP Morgan Analyst | PRVA Stock News - GuruFocus

May 28, 2025

JPMorgan Increases Price Target for Privia Health (PRVA) to $32 - GuruFocus

May 28, 2025

JPMorgan Increases Price Target for Privia Health (PRVA) to $32 | PRVA Stock News - GuruFocus

May 28, 2025

Privia Health Group (NASDAQ:PRVA) Given New $24.00 Price Target at Barclays - Defense World

May 28, 2025

May 27, 2025

11 Analysts Have This To Say About Privia Health Gr - Benzinga

May 27, 2025

Privia Health Gr (PRVA) Sees Price Target Boost by Barclays | PRVA Stock News - GuruFocus

May 27, 2025

Barclays Adjusts Privia Health (PRVA) Price Target Post Q1 | PRV - GuruFocus

May 27, 2025

May 25, 2025

Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Ameriprise Financial Inc. - Defense World

May 25, 2025

May 24, 2025

(PRVA) Long Term Investment Analysis - news.stocktradersdaily.com

May 24, 2025

Privia Health’s SWOT analysis: capital-efficient model drives stock growth - Investing.com

May 24, 2025

May 23, 2025

Cetera Investment Advisers Reduces Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World

May 23, 2025

May 22, 2025

Privia Health Group Approves Key Proposals at Meeting - TipRanks

May 22, 2025

May 20, 2025

Bank of America Corp DE Has $19.98 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World

May 20, 2025

May 15, 2025

Investing in Smarter Healthcare: The New Era of AI-Driven Medicine - The Globe and Mail

May 15, 2025

Unpacking Q1 Earnings: Privia Health (NASDAQ:PRVA) In The Context Of Other Healthcare Technology for Providers Stocks - Yahoo Finance

May 15, 2025

Some May Be Optimistic About Privia Health Group's (NASDAQ:PRVA) Earnings - Yahoo Finance

May 15, 2025

Top Executives Cash In on Privia Health Group Stock - TipRanks

May 15, 2025

May 14, 2025

How the (PRVA) price action is used to our Advantage - news.stocktradersdaily.com

May 14, 2025

The Manufacturers Life Insurance Company Trims Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World

May 14, 2025

May 13, 2025

Privia Health Group, Inc. (NASDAQ:PRVA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Voyager Therapeutics (VYGR) and Privia Health Group (PRVA) - The Globe and Mail

May 13, 2025

Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 13, 2025

May 12, 2025

Privia Health’s Earnings Call Highlights Growth and Challenges - TipRanks

May 12, 2025

Privia Health Group’s Strong Performance and Strategic Expansion Drive Positive Outlook - TipRanks

May 12, 2025

May 11, 2025

Has Privia Health Group, Inc.'s (NASDAQ:PRVA) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - simplywall.st

May 11, 2025

Tower Research Capital LLC TRC Sells 799 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World

May 11, 2025

May 10, 2025

Privia Health Group First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 10, 2025

May 09, 2025

Truist Securities Adjusts Price Target on Privia Health Group to $30 From $28, Maintains Buy Rating - marketscreener.com

May 09, 2025

Privia Health Q1 2025 slides: Strong growth and margin expansion fuel raised guidance - Investing.com

May 09, 2025

Privia Health: Q1 Earnings Snapshot - New Haven Register

May 09, 2025